GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » Cash Receipts from Fees and Commissions
中文

Arovella Therapeutics (ASX:ALA) Cash Receipts from Fees and Commissions


View and export this data going back to 2002. Start your Free Trial

Cash Receipts from Fees and Commissions only applies to banks.


Arovella Therapeutics (ASX:ALA) Business Description

Industry
Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.